A SOX2-engineered epigenetic silencer factor represses the glioblastoma genetic program and restrains tumor

Valerio Benedetti1, Federica Banfi1,2, Mattia Zaghi1

  • 1Stem Cell and Neurogenesis Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.

Science Advances
|August 3, 2022
PubMed

Insights

A novel synthetic repressor, SOX2 epigenetic silencer (SES), effectively targets glioblastoma multiforme (GBM) by silencing SOX2. This approach shows promise in killing cancer cells and tumors while sparing healthy brain cells.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Regulation

Background:

  • Glioblastoma multiforme (GBM) recurrence leads to poor patient survival.
  • Current therapies are insufficient for preventing GBM recurrence.
  • SOX2 is a key transcription factor promoting GBM malignancy.

Purpose of the Study:

  • To engineer a synthetic repressor targeting SOX2 for GBM treatment.
  • To evaluate the efficacy and safety of the SOX2 epigenetic silencer (SES) in preclinical models.

Main Methods:

  • Rational engineering of SOX2 with Kruppel-associated box and DNA methyltransferase3A/L catalytic domains to create SES.
  • In vitro and in vivo testing of SES on glioma cell lines, cancer stem cells, and mouse xenografts.
  • Local viral delivery of SES for tumor treatment.

Main Results:

  • SES induces transcriptional silencing of SOX2 targets, leading to cell death in glioma and cancer stem cells.
  • In vivo, SES expression caused significant tumor regression and improved survival in mouse xenografts.
  • SES demonstrated safety, sparing neurons and glia due to targeted expression in mitotically active cells.

Conclusions:

  • SES effectively represses aggressive brain tumors by silencing the SOX2 network.
  • SES represents a promising therapeutic strategy for glioblastoma multiforme.
  • Targeted delivery and minimal promoter design enhance SES safety and efficacy.

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.1K
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
40.9K
Genomic Imprinting and Inheritance02:30

Genomic Imprinting and Inheritance

Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
35.1K